🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Advanced Cholangiocarcinoma

Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion NCT06439485Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Pemigatinib, Atezolizumab, Bevacizumab Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma NCT07780838Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Gemcitabine A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820Phase 219 sites📍 Phoenix📍 Jacksonville📍 Tampa Elevar Therapeutics · Tests: Lirafugratinib Liver Transplantation in Intrahepatic Cholangiocarcinoma NCT06140134n/a2 sites📍 Newark📍 Newark Rutgers, The State University of New Jersey · Tests: Liver Transplant CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer NCT07614061Phase 11 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine A First in Human Study of PLT012 in Participants With Solid Tumor Cancers NCT07337525Phase 14 sites📍 Los Angeles📍 Dallas📍 Houston Pilatus Biosciences Inc · Tests: PLT012 A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites📍 Beverly Hills📍 Los Angeles📍 Palo Alto Pheast Therapeutics · Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma NCT06956716Phase 1, Phase 21 site📍 Hangzhou Zhejiang University · Tests: individualized anti-tumor new antigen iNeo-Vac-R01 injection, Gemcitabine + cisplatin (GP), Sintilimab injection HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA) NCT07105748Phase 21 site📍 Shanghai Fudan University · Tests: Camrelizumab, Rivoceranib (Apatinib), HAIC Registry for Advanced Endoscopy NCT05187312n/a1 site📍 Stockholm Region Stockholm · Tests: Endoscopic retrograde Cholangio- pancreatography, Endoscopic ultrasound A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors NCT07488676Phase 1, Phase 221 sites📍 Birmingham📍 Los Angeles📍 Miami Astellas Pharma Global Development, Inc. · Tests: ASP546C Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma NCT05823311Phase 31 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Lenvatinib, tislelizumab, gemcitabine and cisplatin, Gemcitabine and cisplatin Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors NCT07334119Phase 17 sites📍 Darlinghurst📍 Randwick📍 Waratah Myeloid Therapeutics · Tests: MT-304, MT-304 + Nivolumab Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab NCT06648057n/a1 site📍 Seongnam-si CHA University · Tests: lenvatinib plus pembrolizumab SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma NCT05568680Phase 15 sites📍 Tampa📍 Westwood📍 Philadelphia Verismo Therapeutics · Tests: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR Pemigatinib + Afatinib in Advanced Refractory Solid Tumors NCT06302621Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Afatinib, Pemigatinib Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) NCT06859684Phase 21 site📍 Chengdu West China Hospital · Tests: Durvalumab, hepatic arterial infusion chemotherapy (HAIC), Lenvatinib BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours NCT04421820Phase 1, Phase 224 sites📍 Santa Monica📍 Tampa📍 Edmonton Bold Therapeutics, Inc. · Tests: BOLD-100 +/- FOLFOX Chemotherapy (Arm VII), BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI) Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194Phase 1, Phase 26 sites📍 Denver📍 Miami📍 Boston ModeX Therapeutics, An OPKO Health Company · Tests: MDX2001 HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma NCT06858735Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Durvalumab, Gemcitabine, Cisplatin The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. NCT07224464NA1 site📍 Rochester New Phase Ltd. · Tests: The Sarah Nanotechnology System - intended to deliver thermal energy to malignant cells for the purpose of thermal dest… TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma NCT04954781Phase 21 site📍 Shanghai Fudan University · Tests: Tislelizumab, TACE Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma NCT05532059Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Lenvatinib, tislelizumab, gemcitabine and cisplatin, gemcitabine and cisplatin A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites📍 Hangzhou📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: CEA-targeted CAR-T cells Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) NCT05451043Phase 21 site📍 Edmonton AHS Cancer Control Alberta · Tests: Durvalumab, Gemcitabine, Nab paclitaxel, Tremelimumab, Propranolol A Study of MGC028 in Participants With Advanced Solid Tumors NCT06723236Phase 17 sites📍 San Francisco📍 Boston📍 Boston MacroGenics · Tests: MGC028 Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma NCT06438822Phase 21 site📍 Chengdu West China Hospital · Tests: Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma NCT06058663Phase 11 site📍 Jacksonville Mayo Clinic · Tests: Angiography, Biopsy, Biospecimen Collection, Computed Tomography, Durvalumab Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio NCT05655949Phase 21 site📍 Boston Beth Israel Deaconess Medical Center · Tests: Gemcitabine, Cisplatin, Durvalumab, Yttrium-90
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy